Virtu KCG Holdings’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q2
$82K Buy
+11,335
New +$82K ﹤0.01% 2460
2017
Q1
Sell
-23,870
Closed -$140K 4038
2016
Q4
$140K Sell
23,870
-15,079
-39% -$88.4K ﹤0.01% 2759
2016
Q3
$207K Buy
+38,949
New +$207K ﹤0.01% 2317
2016
Q2
Sell
-85,452
Closed -$399K 3515
2016
Q1
$399K Buy
85,452
+32,818
+62% +$153K 0.01% 1418
2015
Q4
$266K Buy
52,634
+39,883
+313% +$202K ﹤0.01% 1871
2015
Q3
$45K Sell
12,751
-8,570
-40% -$30.2K ﹤0.01% 2532
2015
Q2
$213K Sell
21,321
-2,115
-9% -$21.1K ﹤0.01% 2034
2015
Q1
$298K Buy
23,436
+5,791
+33% +$73.6K 0.01% 1514
2014
Q4
$250K Buy
+17,645
New +$250K ﹤0.01% 1802
2014
Q3
Sell
-17,580
Closed -$270K 3273
2014
Q2
$270K Buy
+17,580
New +$270K ﹤0.01% 1834
2013
Q4
Sell
-37,126
Closed -$375K 3143
2013
Q3
$375K Buy
+37,126
New +$375K ﹤0.01% 1489